The sickle cell disease implementation consortium: Translating evidence-based guidelines into practice for sickle cell disease

Affiliations

¹ RTI International, North Carolina.
² Brown School of Social Work, Washington University in St. Louis, St. Louis, Missouri.
³ Division of Pediatric Hematology-Oncology, University of Illinois at Chicago, Chicago, Illinois.
⁴ Department of Pediatrics, Medical University of South Carolina, Charleston, South Carolina.
⁵ Department of Emergency Medicine, Icahn School of Medicine at Mount Sinai, New York, New York.
⁶ University of California, San Francisco Benioff Children's Hospital Oakland, Oakland, California.
⁷ Department of Public Health Sciences, Medical University of South Carolina, Charleston, South Carolina.
⁸ Jiann-Ping Hsu College of Public Health, Georgia Southern University, Statesboro, Georgia.
⁹ Division of Epidemiology, Biostatistics, and Environmental Health, School of Public Health, University of Memphis, Memphis, Tennessee.
¹⁰ School of Medicine, Washington University in St. Louis, St. Louis, Missouri.
¹¹ University of California, Davis School of Medicine, Sacramento, California.
¹² Division of Hematology, Duke University School of Medicine, Durham, North Carolina.
¹³ Department of Emergency Medicine and Hospitalist Services, Augusta University, Augusta, Georgia.
¹⁴ Department of Hematology, St. Jude Children's Research Hospital, Memphis, Tennessee.

Lisa D DiMartino et al. Am J Hematol. 2018 Dec.

. 2018 Dec;93(12):E391-E395.

doi: 10.1002/ajh.25282. Epub 2018 Oct 17.

¹ RTI International, North Carolina.
² Brown School of Social Work, Washington University in St. Louis, St. Louis, Missouri.
³ Division of Pediatric Hematology-Oncology, University of Illinois at Chicago, Chicago, Illinois.
⁴ Department of Pediatrics, Medical University of South Carolina, Charleston, South Carolina.
⁵ Department of Emergency Medicine, Icahn School of Medicine at Mount Sinai, New York, New York.
⁶ University of California, San Francisco Benioff Children's Hospital Oakland, Oakland, California.
⁷ Department of Public Health Sciences, Medical University of South Carolina, Charleston, South Carolina.
⁸ Jiann-Ping Hsu College of Public Health, Georgia Southern University, Statesboro, Georgia.
⁹ Division of Epidemiology, Biostatistics, and Environmental Health, School of Public Health, University of Memphis, Memphis, Tennessee.
¹⁰ School of Medicine, Washington University in St. Louis, St. Louis, Missouri.
¹¹ University of California, Davis School of Medicine, Sacramento, California.
¹² Division of Hematology, Duke University School of Medicine, Durham, North Carolina.
¹³ Department of Emergency Medicine and Hospitalist Services, Augusta University, Augusta, Georgia.
¹⁴ Department of Hematology, St. Jude Children's Research Hospital, Memphis, Tennessee.

No abstract available

Figures

1. Brousseau DC, Panepinto JA, Nimmer M, Hoffmann RG. The number of people with sickle-cell disease in the United States: national and state estimates. Am J Hematol. 2010;85(1):77–78. - PubMed
1. American Society of Hematology. State of Sickle Cell Disease: 2016 Report. Accessed June 29, 2018 from http://www.scdcoalition.org/pdfs/ASH%20State%20of%20Sickle%20Cell%20Dise....
1. National Heart Lung and Blood Institute. Evidence-Based Management of Sickle Cell Disease. Expert Panel Report. 2014; Accessed June 29, 2018 from https://www.nhlbi.nih.gov/sites/default/files/media/docs/sickle-cell-dis....
1. Yawn BP, Buchanan GR, Afenyi-Annan AN, et al. Management of sickle cell disease: summary of the 2014 evidence-based report by expert panel members. JAMA. 2014;312(10):1033–1048. - PubMed
1. Stettler N, McKiernan CM, Melin CQ, Adejoro OO, Walczak NB. Proportion of adults with sickle cell anemia and pain crises receiving hydroxyurea. JAMA. 2015;313(16):1671–1672. - PubMed